Dose-ranging effects of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and meta-analysis

被引：0
|
作者：
Pinto, L. C. [1 ]
Rados, D. R. [1 ]
Retnonti, L. R. [1 ]
Viana, M. V. [1 ]
Leitao, C. B. [1 ]
Gross, J. L. [1 ]
机构：
[1] Univ Fed Rio Grande do Sul, Endocrine Div, Porto Alegre, RS, Brazil
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
645
引用
收藏
页码：S313 / S313
页数：1
相关论文
共 50 条
  • [11] Dose-dependent renoprotection efficacy of sglt2 inhibitors in type 2 diabetes: systematic review and network meta-analysis
    Hegde, Naveen C.
    Kumar, Ankit
    Patil, Amol N.
    Bhattacharjee, Samiksha
    Gamad, Nanda
    Kasudhan, Kripa Shanker
    Kumar, Vivek
    Rastogi, Ashu
    ACTA DIABETOLOGICA, 2023, 60 (10) : 1311 - 1331
  • [12] Dose-dependent renoprotection efficacy of sglt2 inhibitors in type 2 diabetes: systematic review and network meta-analysis
    Naveen C. Hegde
    Ankit Kumar
    Amol N. Patil
    Samiksha Bhattacharjee
    Nanda Gamad
    Kripa Shanker Kasudhan
    Vivek Kumar
    Ashu Rastogi
    Acta Diabetologica, 2023, 60 : 1311 - 1331
  • [13] Effects of SGLT2 inhibitors on the cardiovascular outcomes in patients with cancer: a systematic review and meta-analysis
    Liu, L.
    Chen, H. H.
    Kuo, H. H.
    Lin, P. L.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [14] Effects of SGLT2 inhibitors on cardiovascular outcomes and mortality in type 2 diabetes A meta-analysis
    Zou, Cai-Yan
    Liu, Xue-Kui
    Sang, Yi-Quan
    Wang, Ben
    Liang, Jun
    MEDICINE, 2019, 98 (49)
  • [15] SGLT2 inhibitors and renal outcomes in type 2 diabetes with or without renal impairment: A systematic review and meta-analysis
    Seidu, Samuel
    Kunutsor, Setor K.
    Cos, Xavier
    Gillani, Syed
    Khunti, Kamlesh
    PRIMARY CARE DIABETES, 2018, 12 (03) : 265 - 283
  • [16] SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials
    Tang, Huilin
    Dai, Qi
    Shi, Weilong
    Zhai, Suodi
    Song, Yiqing
    Han, Jiali
    DIABETOLOGIA, 2017, 60 (10) : 1862 - 1872
  • [17] SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials
    Huilin Tang
    Qi Dai
    Weilong Shi
    Suodi Zhai
    Yiqing Song
    Jiali Han
    Diabetologia, 2017, 60 : 1862 - 1872
  • [18] The efficacy and safety of SGLT2 inhibitors for adjunctive treatment of type 1 diabetes: a systematic review and meta-analysis
    Chen, Jiao
    Fan, Fang
    Wang, J. Y.
    Long, Yang
    Gao, C. L.
    Stanton, R. C.
    Xu, Yong
    SCIENTIFIC REPORTS, 2017, 7
  • [19] The efficacy and safety of SGLT2 inhibitors for adjunctive treatment of type 1 diabetes: a systematic review and meta-analysis
    Jiao Chen
    Fang Fan
    J. Y. Wang
    Yang Long
    C. L. Gao
    R. C. Stanton
    Yong Xu
    Scientific Reports, 7
  • [20] Effects of SGLT2 inhibitors on hepatic fibrosis and steatosis: A systematic review and meta-analysis
    Zhou, Peipei
    Tan, Ying
    Hao, Zhenning
    Xu, Weilong
    Zhou, Xiqiao
    Yu, Jiangyi
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
12345